PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 368.60
Bid: 368.40
Ask: 368.80
Change: 1.20 (0.33%)
Spread: 0.40 (0.109%)
Open: 360.20
High: 369.20
Low: 360.20
Prev. Close: 367.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adoption of FRS 101 - Reduced Disclosure Framework

11 Feb 2016 07:00

RNS Number : 5841O
QinetiQ Group plc
11 February 2016
 

11 February 2016

 

QinetiQ Group plc

 

On 10 February 2016, QinetiQ Group plc posted a letter to shareholders, the full text of which is set out below.

 

Notification to Shareholders in accordance with Financial Reporting Standard 101

 

The purpose of this letter is to notify shareholders of the proposal to adopt a new financial reporting basis for the parent company financial statements of QinetiQ Group plc ('the Company').

 

The parent company financial statements of QinetiQ Group plc (the 'Company'), as set out on pages 137 to 139 of the QinetiQ Group plc Annual Report for the year ended 31 March 2015, were prepared in accordance with UK Generally Accepted Accounting Practice. The UK Financial Reporting Council ('FRC') has issued a new financial reporting framework which took mandatory effect for accounting periods commencing on or after 1 January 2015. Accordingly the Company is required to prepare its parent company financial statements on one of the new bases permitted by the FRC.

 

The Company proposes to adopt Financial Reporting Standard 101: Reduced Disclosure Framework ('FRS 101') for its parent company financial statements for the year ending 31 March 2016 and on an ongoing basis, until such time as the Company notifies shareholders of any change to its chosen accounting framework for the parent company financial statements. FRS 101 enables a company to use the same recognition and measurement principles of EU International Financial Reporting Standards but also take advantage of a number of specified disclosure exemptions.

 

The consolidated financial statements of the QinetiQ Group will continue to be prepared in accordance with EU International Financial Reporting Standards and are unaffected by the new financial reporting framework.

 

The Company's proposal to adopt FRS 101 for its parent company financial statements does not require shareholder approval. It is necessary, however, for the Company to notify shareholders in writing of the proposed use of the disclosure exemptions permitted under FRS 101. A shareholder or shareholders holding in aggregate 5% or more of the total allotted shares in the Company may serve objections to the use of the disclosure exemptions. Objections must be served in writing and delivered to the Company Secretary at the Company's registered office, Cody Technology Park, Ively Road, Farnborough, Hampshire GU14 0LX, United Kingdom, by no later than 10 March 2016.

 

Please note that if you do not have any objections to this proposal, you do not need to take any further action.

 

In accordance with Listing Rule 9.6.1, a copy of the notification sent to shareholders has been submitted to the National Storage Mechanism and will shortly be available at www.hemscott.com/nsm.do.

 

This announcement is made pursuant to Listing Rule 9.6.3.

 

Contact: Jon Messent, Company Secretary

Tel: 01252 392000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGGZLLGGVZM
Date   Source Headline
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20245:45 pmRNSUpdate statement on 2023 AGM voting results
10th May 20244:17 pmRNSDirector/PDMR Shareholding
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
30th Apr 20244:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:01 amRNSDirectorate Change, Leadership Team appointments
16th Apr 20247:00 amRNSQinetiQ Group plc Fourth Quarter Trading Update
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20244:35 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSDirectorate Change
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20245:24 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20244:05 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20245:21 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.